1. Myths and Truths about Placebo Effect in Rehabilitation for Musculoskeletal Pain

   • Giovanni Iolascon
   • Antimo Moretti

   Commentary Open access 02 September 2021 Pages: 4995 - 5001

2. Health-Related and Economic Burden Among Family Caregivers of Patients with Acute Myeloid Leukemia or Hematological Malignancies

   • Emre Yucel
   • Shiyu Zhang
   • Sumeet Panjabi

   Review Open access 09 September 2021 Pages: 5002 - 5024

   

3. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review

   • Sara J. Menown
   • Javier A. Tello

   Review Open access 12 September 2021 Pages: 5025 - 5045

   

4. Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications

   • Warner W. Carr
   • Neal Jain
   • J. Wesley Sublett

   Review Open access 13 September 2021 Pages: 5046 - 5064

   

5. Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review

   • Mengyuan Peng
   • Xiaozhong Guo
   • Xingshun Qi

   Review 15 September 2021 Pages: 5065 - 5077

   

6. Application of Artificial Intelligence in Acute Coronary Syndrome: A Brief Literature Review

   • Hong Wang
   • Quannan Zu
   • Mohammad Anis Ahmed

   Review 15 September 2021 Pages: 5078 - 5086

   

7. A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States

   • Linda Harris
   • Gilbert L’Italien
   • Sylvia Lucas

   Original Research Open access 31 May 2021 Pages: 5087 - 5097

   

8. Correction to: A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States

   • Linda Harris
   • Gilbert L’Italien
   • Sylvia Lucas

   Correction 13 September 2021 Pages: 5098 - 5099

9. Analysis of Medication Prescriptions for Hypertension in a Class 1 and Grade A Hospital in Shanxi Province

   • Zhen Li
   • Siyang Wang
   • Ruiqing Zhang

   Original Research 19 August 2021 Pages: 5100 - 5115

   

10. Cost-Effectiveness Analysis of Anlotinib as Third- or Further-Line Treatment for Relapsed Small Cell Lung Cancer (SCLC) in China

    • Jinhong Gong
    • Qian Wan
    • Guangjun Liu

    Original Research 21 August 2021 Pages: 5116 - 5126

    

11. Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population

    • David Lin
    • François Laliberté
    • John F. Paolini

    Original Research Open access 21 August 2021 Pages: 5127 - 5143

    

12. Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis

    • Andrés Coca-Pelaz
    • Juan P. Rodrigo
    • Alfio Ferlito

    Original Research 22 August 2021 Pages: 5144 - 5164

    

13. Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study

    • Or Assouline
    • Eli Ben-Chetrit
    • Sharon Einav

    Original Research 22 August 2021 Pages: 5165 - 5177

    

14. The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis

    • Binkai Yang
    • Tian Wang
    • Yuanjing Hu

    Original Research 21 August 2021 Pages: 5178 - 5190

    

15. Comparison of the Effect and Complications of Sequential Bilateral Arthroplasty at Different Time Intervals and Simultaneous Bilateral Total Knee Arthroplasty: A Single-Centre Retrospective Cohort Study

    • Shenqi Zhang
    • Fengyan Wang
    • Benlong Wang

    Original Research 28 August 2021 Pages: 5191 - 5208

    

16. Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant

    • Karissa M. Johnston
    • Gilbert L’Italien
    • Richard B. Lipton

    Original Research Open access 29 August 2021 Pages: 5209 - 5220

    

17. Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant

    • Hrishikesh P. Kale
    • Zaina P. Qureshi
    • Ruth Benca

    Original Research Open access 31 August 2021 Pages: 5221 - 5237

    

18. Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia

    • Erin E. Cook
    • Jill Davis
    • Eric Q. Wu

    Original Research Open access 01 September 2021 Pages: 5238 - 5252

    

19. Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial

    • Alice B. Gottlieb
    • Richard B. Warren
    • Valerie Ciaravino

    Original Research Open access 02 September 2021 Pages: 5253 - 5269

    

20. Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe

    • Federico Rea
    • Laura Savaré
    • Giuseppe Mancia

    Original Research Open access 03 September 2021 Pages: 5270 - 5285

    

21. Effectiveness of the 10 cm² Rivastigmine Patch in Taiwanese Patients with Mild-to-Moderate Alzheimer’s Dementia: A 48-Week Real-World Observational Study

    • Chiung-Chih Chang
    • Lung Chan
    • Chaur-Jong Hu

    Original Research Open access 10 September 2021 Pages: 5286 - 5301

    

22. Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis

    • Martin Bergman
    • Christopher D. Saffore
    • Haley B. Naik

    Original Research Open access 13 September 2021 Pages: 5302 - 5316

    

23. Therapeutic Drug Monitoring Strategies for Envarsus in De Novo Kidney Transplant Patients Using Population Modelling and Simulations

    • Emilie Henin
    • Mirco Govoni
    • Giovanni Piotti

    Original Research 12 September 2021 Pages: 5317 - 5332

    

24. Health Care Costs in Patients with and without Secondary Hyperparathyroidism in Spain

    • Enrique Alonso-Perez
    • Carles Forné
    • Jose M. Valdivielso

    Original Research 14 September 2021 Pages: 5333 - 5344

    

25. Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies

    • Jonathan Barratt
    • Wladyslaw Sulowicz
    • Botond Csiky

    Original Research Open access 14 September 2021 Pages: 5345 - 5360

26. Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)

    • Botond Csiky
    • Michael Schömig
    • Wladyslaw Sulowicz

    Original Research Open access 19 September 2021 Pages: 5361 - 5380

    

27. Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial

    • Robert A. Wise
    • Benjamin M. Scirica
    • Kenneth R. Chapman

    Original Research Open access 15 September 2021 Pages: 5381 - 5397

    

28. Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR

    • Carmen M. Labandeira
    • Maria G. Alonso Losada
    • Diego Santos García

    Original Research Open access 15 September 2021 Pages: 5398 - 5411

    

29. Efficacy and Safety of Ciprofol Sedation in ICU Patients with Mechanical Ventilation: A Clinical Trial Study Protocol

    • Yongjun Liu
    • Chuanxi Chen
    • Xiangdong Guan

    Study Protocol Open access 21 August 2021 Pages: 5412 - 5423

30. Correction to: Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences

    • Henrik Svedsater
    • Helen A. Doll
    • Magdalena Vanya

    Correction 03 September 2021 Pages: 5424 - 5424